IRIS
MINUTOLO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.407
EU - Europa 4.613
AS - Asia 626
AF - Africa 15
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 10.687
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.393
IE - Irlanda 1.655
UA - Ucraina 836
GB - Regno Unito 644
IT - Italia 411
CN - Cina 395
DE - Germania 348
SE - Svezia 225
FI - Finlandia 209
TR - Turchia 165
GR - Grecia 130
FR - Francia 47
BE - Belgio 37
RU - Federazione Russa 34
CA - Canada 12
IR - Iran 12
PH - Filippine 11
KR - Corea 10
NL - Olanda 10
ES - Italia 9
EU - Europa 7
SG - Singapore 6
IN - India 5
SC - Seychelles 5
CL - Cile 4
HK - Hong Kong 4
CO - Colombia 3
HU - Ungheria 3
ID - Indonesia 3
JP - Giappone 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
BD - Bangladesh 2
BG - Bulgaria 2
BR - Brasile 2
EG - Egitto 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
RS - Serbia 2
RW - Ruanda 2
TH - Thailandia 2
UG - Uganda 2
VN - Vietnam 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HR - Croazia 1
KE - Kenya 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 10.687
Salva come PNG Salva come JPEG
Città #
Dublin 1.654
Jacksonville 1.275
Chandler 923
Chicago 465
Princeton 249
Wilmington 226
Medford 213
Roxbury 154
Boardman 150
Ann Arbor 139
Falls Church 133
San Mateo 125
Beijing 101
Woodbridge 97
Nanjing 57
Bremen 56
Caserta 54
New York 53
Des Moines 52
Cambridge 41
Jinan 38
Brussels 37
Saint Petersburg 32
Houston 30
Mountain View 28
Norwalk 26
Napoli 25
Shenyang 23
Zhengzhou 21
Naples 19
Ashburn 17
Milan 17
Ningbo 13
Tianjin 13
Auburn Hills 12
Guangzhou 12
Rome 12
San Francisco 12
Los Angeles 11
Nanchang 11
Changsha 10
Hangzhou 10
Seattle 10
Taizhou 10
Zanjan 10
Helsinki 9
Redwood City 9
Düsseldorf 8
Hebei 8
Jiaxing 8
Kunming 8
Lanzhou 8
Taiyuan 8
Castel Volturno 7
Florence 7
Haikou 6
Ottawa 6
Shanghai 6
Fairfield 5
Melito di Napoli 5
Aversa 4
Bologna 4
Cantù 4
Cattolica 4
Frankfurt am Main 4
Groningen 4
Lappeenranta 4
London 4
Munich 4
Torino 4
Catania 3
Dearborn 3
Edinburgh 3
Hanover 3
Hong Kong 3
Madrid 3
Padova 3
Potenza 3
Prilep 3
Quezon City 3
Sacramento 3
Santiago 3
Turin 3
Verona 3
Aci Catena 2
Amsterdam 2
Atlanta 2
Bekasi 2
Bitlis 2
Bogotá 2
Brusciano 2
Cagliari 2
Calgary 2
Caloocan City 2
Casablanca 2
Castelnuovo Rangone 2
Cesena 2
Chittagong 2
Dong Ket 2
Dortmund 2
Totale 6.898
Salva come PNG Salva come JPEG
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 768
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 114
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 89
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 76
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 75
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 71
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 69
[Anti-diabetics and chronic kidney disease] 68
Daily nutrient intake in hemodialysis. 65
Epidemiology of chronic kidney disease in Italy: the CARHES study 65
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 65
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 65
Inibizione dell’angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale 64
Amino acid loss during dialysis treatment 64
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 64
Empagliflozin in Patients with Chronic Kidney Disease 63
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 63
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 63
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 62
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 60
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 60
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 59
Effetto antiproteinurico di ACE inibitori e Losartan e polimorfismo del gene dell’ACE 59
Management of hypertension in chronic kidney disease: the Italian multicenter study. 57
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 56
Epidemiology of chronic kidney disease in Italy. J Nephrol 2010;23 (Suppl 15):S16-22 56
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 55
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 55
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 54
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 54
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 54
Effects of efficiency and length of acetate-free biofiltration session on post-dialysis solutes rebound 54
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 54
Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-up 54
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 53
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 53
Management of hypertension in chronic kidney disease: the italian multicentric study 53
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 53
Disfunzione renale nell’anziano: processo fisiologico o malattia? 53
Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? 53
CALCOLOSI RENALE 53
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 53
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 52
Management of hypertension in chronic kidney disease 52
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 52
Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care 52
Epidemiology of CKD Regression in Patients under Nephrology Care 52
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 51
Heart Failure in chronic kidney disease: from epidemiology to therapy. 51
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 51
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 51
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 51
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 50
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. 50
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 50
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 49
Effect of a low- versus moderate-protein diet on progression of CKD: Follow-up of a randomized controlled trial 49
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 49
Stability of target hemoglobin levels during the first year of epoetin treatment in CKD patients. 49
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 49
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 48
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 48
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 48
Manuale di Terapia delle Malattie Renali 48
[Iron deficiency in ND-CKD: from diagnosis to treatment] 48
[Hyperuricaemia and Chronic Kidney Disease] 48
Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study 47
Intradialytic changes of plasma amino acid levels: effect of hemodiafiltration with endogenous reinfusion versus acetate-free biofiltration 47
Hyponatremia secondary to inappropriate antidiuretic hormone secretion. 47
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 47
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 47
Resistant hypertension in nondialysis chronic kidney disease. 47
Epoetin therapy and hemoglobin level variability in non-dialysis CKD patients 46
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 46
Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes 46
Sodium/Glucose Cotransporter 2 Inhibitors and Prevention of Diabetic Nephropathy: Targeting the Renal Tubule in Diabetes 46
Epidemiology of chronic kidney disease in Italy 46
Ruolo dell'endotelina-1 nelle modificazioni acute dell'emodinamica renale da mezzo di contrasto in pazienti con ridotta funzione renale 46
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 46
Aumento della reattività vascolare in risposta a variazioni del flusso in arterie mesenteriche di ratto isolate e perfuse 46
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 46
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 46
Responsiveness to erythropoiesis-stimulating agents in chronic kidney disease: does geography matter? 45
Clinical policies on the management of chronic kidney disease patients in Italy 45
Hypertension in patients on hemodialysis: the role of salt intake. 45
Diagnostic role of ambulatory blood pressure monitoring in non-dialysis CKD patients 45
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 45
Patogenesi del rebound post-dialitico del fosforo 45
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice. 45
Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study. 45
[Epidemiology and prognosis of chronic kidney disease in Italy] 45
AISF position paper on HCV in immunocompromised patients 45
Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial 44
Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial 44
Epoetin therapy and hemoglobin level variability in nondialysis patients with chronic kidney disease 44
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 44
Effects of age on hypertensive status in patients with chronic kidney disease 44
Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients. 44
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 44
Supplemented very low-protein diet in advanced CRF: is it money saving? 43
Totale 6.039
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201935 0 0 0 0 0 0 0 0 0 0 11 24
2019/20201.313 323 235 9 11 223 14 251 22 120 47 47 11
2020/20211.859 177 14 224 137 358 8 240 203 17 251 179 51
2021/20221.805 158 42 46 74 539 15 37 51 65 146 161 471
2022/20233.672 323 110 313 299 343 307 11 219 1.567 36 65 79
2023/2024981 121 45 54 118 464 68 45 20 20 23 3 0
Totale 11.033